AniClin conducts a wide range of metabolism studies and focuses on those studies recommended by FDA. This includes studies designed to identify metabolic pathways and studies that investigate potential drug-drug interactions.
Services:

• Mass balance studies for excretion, quantitative tissue distribution and expired air
• Metabolic profiling by HPLC with UV/Fluorescence detection and mass spectrometry
• In vivo services, including dosing of animals, collection and processing of samples for analysis